DNMT1 and cancer: The methylation of the 5-carbon on cytosine residues (5mC) in CpG dinucleotides was the first described covalent modification of DNA and is one of the most extensively characterised modifications of chromatin, and thus, DNMT inhibitors have become useful tools for treating cancers.4